KLRK1 and neoplasm: MICA-gene-specific transcriptional activation and overexpression by tumor cells using CRISPR/Cas9 technology were studied by Sekiba and colleagues and resulted in increased NKG2D-mediated clearance of the targeted cells in vitro [78,79].